Robin Walker Net Worth & Insider Trades

Robin Walker - Chief Legal Officer, Stoke Therapeutics, Inc

As of July 9, 2020

What is Robin Walker's Net Worth?

The current estimated net worth of Stoke Therapeutics, Inc's Chief Legal Officer, Robin Walker, is estimated to be about $21.17K . Robin Walker owns about 0 unit of Stoke Therapeutics, Inc common stock. In the last year at Stoke Therapeutics, Inc, Robin Walker has sold an estimated value of $21.17K worth.

What is Robin Walker's Past Insider Trading?

Robin Walker's largest sale order was 941 units , worth over $21.17K on July 9, 2020. In total, Robin Walker has made about 3 transactions over a year of their time at Stoke Therapeutics, Inc. Robin Walker usually trades in November, March and July, with the busiest year in 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Robin Walker's' Mailing Address?

  • Mailing address is C/o Stoke Therapeutics, Inc. 45 Wiggins Ave Bedford MA 01730 MA

What are Stoke Therapeutics, Inc's Past Insider Trades?

Stoke Therapeutics, Inc's most recent insider trade came on July 6, 2023 by Barry Ticho who sold 15,000 units worth $158.97K . In the last 4 years, insiders at Stoke Therapeutics, Inc have sold an estimated value of $25.86M and bought an estimated value of $96.33M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Huw Nash, COO & CBO,  Barry Ticho, Chief Medical Officer,  and MD Edward Kaye, CEO .

Stoke Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...